FDA Issues Final Rule on Nonprescription Drug Marketing with Additional Condition for Use
- January 10, 2025
A final rule (89 Fed. Reg. 105288) published December 26, 2024 establishes requirements for marketing a drug product without a prescription if a manufacturer implements an additional condition for nonprescription use (ACNU).
ARTICLE TAGS
You must be logged in to access this content.